Products
홈
Products
Ribestin®
Ribestin®
Products 04
Ribestin®Scientifically proven Cornus officinalis & Ribes fasciculatum for in weight management and female health in menopause US FDA NDI(New Dietary Ingredient) notified ingredientFunctional Health Claim
- Support weight management by body fat reduction
- Support female health in menopause
Dosage
- 1,600 mg / day as Cornus officinalis and Ribes fasciculatum complex
Active Compound
| Name | Loganin |
|---|---|
| Molecular Formula | C17H26O10 |
| Molecular Weight | 390.38 |
| CAS No. | 18524-94-2 |
| Name | 4-Hydroxybenzoic acid |
|---|---|
| Molecular Formula | C7H6O3 |
| Molecular Weight | 138.12 |
| CAS No. | 99-96-7 |
Clinical Trial
1Weight Management
- Subject76 women aged 20–65 years, with a body mass index (BMI) of 25 to 29.9 kg/m2
- MethodTake Ribestin® 1600 mg/day for 12 weeks
A multicenter, double-blind, randomized, and placebo-controlled study
Body fat mass decreased
2.2 times to placebo
Percentage body fat decreased
76 times to placebo
2Female health in Menopause
- Subject90 women aged 40–60 years, who complain of menopausal symtoms
- MethodTake Ribestin® 1600 mg/day for 12 weeks
A multicenter, double-blind, randomized, and placebo-controlled study
Total score of MRS : 68 % ↓
MRS Irritability : 24 % ↓
MRS Anxiety : 53 % ↓
Compare to placebo, After 12 weeks
MRS Bladder problems : 67 % ↓
Patents
| Patent name | Registration status |
|---|---|
| COMPOSITION FOR PREVENTING, IMPROVING OR TREATING WOMAN MENOPAUSE-RELATED DISEASE | KP Registered |
-
KP10-2030495
(2019.10.02)
| Patent name | Registration status |
|---|---|
| COMPOSITION FOR PREVENTING , IMPROVING OR TREATING FEMALE MENOPAUSAL DISEASE | USP Registered |
-
US 11646817
(2022.10.11)